Large-Scale
Distributor Plans + Positive #CBD Financials Bolster Market Despite Regulatory
Issues (OTCQB: $NLBS) (OTCQX: $CWBHF)
(NASDAQ: $VFF) (NYSE: $APHA)
Point Roberts WA,
Delta BC – April 8, 2019 - Investorideas.com, a leading investor news resource covering
hemp and cannabis stocks releases a market snapshot discussing how the recent
influx of positive 2018 financials have helped embolden the CBD market and showcase
its progress in spite of unclear government regulations.
As discussed in a recent Forbes article “the two biggest
pharmacy chains in the United States decided that CBD was worth exploring. Both CVS and Walgreens announced – within
days of each other – that they would begin selling hemp-derived CBD products in
2,300 stores between the two nationwide chains. While you won’t find the trendy
CBD products listed at these drugstores, their shelves will soon contain a
variety of topical applications like creams, lotions, salves, patches, and
sprays.”
Continued: “The fact
that nationally recognized brands are putting their weight behind
cannabis-tangential products is almost certainly a harbinger of things to come
– even if the complex reality of FDA regulations forces the drugstore chains to
limit their CBD product lines to topical applications for practical and legal
reasons.”
This endorsement of
the CBD sector is only emboldened further with the recent string of positive
2018 financials coming out
Read this in full at https://www.investorideas.com/news/2019/cannabis/04082Stocks-Distributor-CBD.asp
NutraLife Biosciences, Inc. (OTCQB: NLBS), a company that develops,
manufactures, and distributes nutraceutical, wellness, and CBD products, under
the NutraHempCBD brand and oral spray vitamins and supplements under the
NutraSpray brand, recently announced revenue growth of approximately 107.3% in
2018, the filing of its Annual Report on Form 10-K and audited financial
results. Some of the highlights from the Company’s financial results reported in its Form
10-K for the year ended December 31, 2018 include: increased sales to
$3,711,327 for the year ended December 31, 2018 compared to $1,790,168 for the
year ended December 31, 2017, an increase of approximately 107.3%, cost of
sales was $2,211,039 compared to $1,055,042 for the years ended December 31,
2018 and 2017, respectively, or a 109.6% increase, gross margin for the year
ended December 31, 2018 was $1,500,288, a 104.1% increase over the year ended
December 31, 2017 and sales of CBD products increased from approximately
$1,380,000 for the year ended December 31, 2017 to $2,400,000 for the year
ended December 31, 2018 representing 77% and 78% of our revenues for such
periods.
Edgar Ward, Founder and Chief Executive Officer of
NutraLife Biosciences recently commented on the CVS CBD news, saying “It is
encouraging to see that mainstream retail giants like CVS are offering hemp
derived CBD products to consumers.”
Charlotte's
Web Holdings Inc. (CSE: CWEB) (OTCQX: CWBHF), the market share leader in
hemp-derived CBD extract products, recently reported financial
results for the fourth quarter and year ended December 31, 2018. Some of the
highlights of Fourth Quarter 2018 Results versus Fourth Quarter 2017 Results
were: an organic consolidated revenue growth of 71% to $21.5 million (up 21%
QoQ), gross profit increased 63% to $16.3 million, or 76% of consolidated
revenue, adjusted EBITDA decreased from 37% to 20% of consolidated revenue, due
to extraordinary items and 57% of revenue from eCommerce.
Village Farms International, Inc. (TSX: VFF) (NASDAQ: VFF) just recently announced its financial
results for the fourth quarter and year ended December 31, 2018.
Some of the financial
and corporate highlights for the Fourth Quarter Ended December 31, 2018
included: a net income improved of US$0.3 million, or US$0.01 per share, sales,
including the Company's proportionate share of Pure Sunfarms' sales, increased
to US$40.6 million compared with US$36.9 million, EBITDA, was US$1.5 million
compared with US$2.6 million. EBITDA included $0.9 million from Pure Sunfarms
and the Company's common shares commenced trading on the Nasdaq Capital Market
under the symbol "VFF".
While most eyes are currently on the US CBD market, Aphria Inc. (TSX: APHA) (NYSE: APHA)
through its subsidiary Aphria Deutschland GmbH is focusing on other markets
having recently launched the Company's
first CBD-based nutraceutical, the first product in its CBD-based cosmetics
line for the German market. Featuring CBD derived from hemp, the CannRelief
brand of products are being produced in the European Union and distributed by
the Company's subsidiary, CC Pharma, which has access to more than 13,000 pharmacies
throughout Germany.
Before we see more
major chains really double down on the cannabis landscape, a new regulatory
framework will have to be developed and implemented, providing guidance for
what these companies can and can’t do. Though we may be a long way off from
that framework coming into place, a continued string of positive financials and
interest from large parties like this is encouraging to see and helps give
credence to the industry.
For investors
following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana/Hemp Stocks
About Investorideas.com
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Follow us on Cannabis Social Media
Disclaimer/Disclosure:.
Our site does not make recommendations for purchases or sale of stocks, services
or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investment involves
risk and possible loss of investment. This site is currently compensated for
news publication and distribution, social media and marketing, content creation
and more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this
article featuring NutraLife Biosciences Inc. (OTC: NLBS) is a paid for service on Investorideas.com (
third party). Learn more about costs and our services https://www.investorideas.com/News-Upload/
Global investors must
adhere to regulations of each country.
Investor Ideas does not condone the use of cannabis
except where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment